FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

10908311000001100: Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
37362401000001114 Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
37362501000001113 Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction individual patient supply true Inferred relationship Existential restriction modifier
Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) Is a Product containing precisely flucytosine 500 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) Has active ingredient Flucytosine false Inferred relationship Existential restriction modifier
Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) Is a Ancotil true Inferred relationship Existential restriction modifier
Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) Has specific active ingredient Flucytosine true Inferred relationship Existential restriction modifier
Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) 100 tablet Is pack of False Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) Inferred relationship Existential restriction modifier
Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) 100 tablet Has AMP True Ancotil 500mg tablets (ICN Pharmaceuticals France S.A.) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start